Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Genome Biology|September 7, 2020
The Tug1 lncRNA locus is essential for male fertilityJordan P Lewandowski, Gabrijela Dumbović, Audrey R Watson, et al.Cancer Discovery|May 29, 2014
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibitionEnrique González-Billalabeitia, Nina Seitzer, Su Jung Song, et al.Nature Genetics|June 4, 2013
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.Nature Genetics|September 5, 2020
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.Cancer Research Communications|March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin TreatmentGiorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.Research Square|January 30, 2023
Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerabilityShizhong Ke, Fabin Dang, Lin Wang, et al.Nature Genetics|January 17, 2018
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancerMing Chen, Jiangwen Zhang, Katia Sampieri, et al.JCI Insight|September 29, 2020
PDX-derived organoids model in vivo drug response and secrete biomarkersLing Huang, Bruno Bockorny, Indranil Paul, et al.Cell|August 13, 2021
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapyKazuhiro Koikawa, Shin Kibe, Futoshi Suizu, et al.Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.Pageof 6